Status:
RECRUITING
The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder
Lead Sponsor:
Father Flanagan's Boys' Home
Collaborating Sponsors:
University of Iowa
National Institutes of Health (NIH)
Conditions:
Developmental Language Disorder
Healthy Subjects
Eligibility:
All Genders
5-10 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to determine how memory and attention affect the ability of children with developmental language disorder (DLD) to learn and use new vocabulary.
Detailed Description
The goal of this clinical trial is to determine how memory and attention affect the ability of children with developmental language disorder (DLD) to learn and use new vocabulary. Aims 1-3 include ch...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Has DLD or typical language development
- Exclusion Criteria
- Has not been exposed to English since birth
- Has other neurodevelopmental or sensory condition that could explain the language problem (e.g., intellectual disability, autism, hearing loss).
Exclusion
Key Trial Info
Start Date :
February 9 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2030
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06968169
Start Date
February 9 2025
End Date
June 1 2030
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boys Town National Research Hospital
Omaha, Nebraska, United States, 68131